Epstein Secrets

st (11/27, Papenfuss). Supreme Court Set to Take Up All-Or-Nothing Abortion Fight The Associated Press (11/28, Sherman) reported that on Wednesday, the U.S. Supreme Court will hear arguments in a potential landmark case concerning reproductive rights. According to the article, the case comes from Mississippi, where a

Pick Joins Fray Over Trump Jan. 6 Subpoena The Hill (11/28, Kruzel) reported that Ketanji Jackson, seen by Democrats as a top contender for a future Supreme Court vacancy, is one of three judges assigned the weighty task of reviewing former President Trump's bid to block a congressional subpoena for records re

safeguarding public health through inoculations, masking indoors and distancing, remains critical." Coverage also quoted Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases (NIAID), who said that it is "inevitable" that the variant will reach the United States, and that its impending arrival is another reason to get va

) reports, "The Democratic National Committee, which had sought the accommodations, could appeal the decision, either to the full 7th Circuit or to the U.S. Supreme Court. A spokeswoman did not immediately respond to a request for comment." Kagan Refuses To Block Montana Ballot-Mailing. The AP (10/8) reports, "A fina

ed." NIAID Marks Start Of Convalescent Plasma Study. The Wall Street Journal (10/8, Walker, Hopkins, Subscription Publication, 7.57M) reports that the National Institute of Allergy and Infectious Diseases announced a study testing the use of convalescent plasma in comparison to remdesivir for the treatment of coronavirus. The NIAID- funded study, led

Democratic National Committee, which had sought the accommodations, could appeal the EFTA01658608 decision, either to the full 7th Circuit or to the U.S. Supreme Court. A spokeswoman did not immediately respond to a request for comment." Kagan Refuses To Block Montana Ballot-Mailing. The AP (10/8) reports, "A fina

ed." NIAID Marks Start Of Convalescent Plasma Study. The Wall Street Journal (10/8, Walker, Hopkins, Subscription Publication, 7.57M) reports that the National Institute of Allergy and Infectious Diseases announced a study testing the use of convalescent plasma in comparison to remdesivir for the treatment of coronavirus. The NIAID- EFTA01658603 fun